Curriculum Vitae - www.drjankowski.pl

Marek Jankowski
[email protected]
Tel +48 695696891
Curriculum Vitae
Education
present
graduate student
Dept of Gene Therapy, Nicolaus Copernicus Univ.
2007
Doctor of Medicine Faculty of Medicine, Nicolaus Copernicus University
2007
M.Sc. in Biotechnology Department of Genetics, Faculty of Biology,
Nicolaus Copernicus University; Thesis: 'Cloning of recombinant single
peptide interleukin IL-27 and its expression in cancer cell lines by retroviral
gene transfer'
2005
B.Sc. in Biotechnology Dept. Of Genetics, Faculty of Biology, Nicolaus
Copernicus University in Torun. Thesis: 'Genetic basis of familial forms of
Parkinson's Disease',
Scientific experience
10-12.2007
Universitaetsmedizin Charite Berlin, Germany, prof. C. Hanski research
group; Project: Molecular mechanisms of UDCA-mediated prevention of
colon cancer.
09.2006
Centre National de la Recherche Scientifique (lab 5165), Toulouse,
France, prof. M. Guerrin-Weber research group; Project : Identification of a
new dermokine isoforms.
07-09.2005
Max-Planck-Institute of Immunobiology, Freiburg, Germany; dr J. Kirberg
research group; Project: Retroviral mutagenesis for positive Th1 selection.
09.2004
Institut fur Medizinischebiologie und Humangenetik Graz, Austria;
dr C. Windpassinger research group; Project: Search for new mutations in
hereditary neuropathies.
09.2003
Department of Tropical Medicine, University of Tanta, Tanta, Egypt;
clinical internship in tropical medicine
Peer reviewed publications & presentations
1)Jankowski M: Rola szlaku JNK w rodzinnych postaciach choroby Parkinsona. Postepy Biochem.
53 (2007), 3: 297- 303
2)Kopinski P, Przybylski G, Jarzemska A, Sladek K, Soja J, Iwaniec T, Balicka-Slusarczyk B, Pinis G,
Dyczek A, Bartczak K, Golinska J, Jankowski M & Szczeklik J: Stężenie interferonu gamma w płynie z
płukania oskrzelowo-pęcherzykowego w wybranych chorobach śródmiąższowych płuc – dodatnio
skorelowane z wartością stosunku CD4/CD8. Pol Merkur Lekarski 2007, 133: 15-21
3)Jankowski M, Kopiński P, Goc A. "Interleukin-27: Biological Properties and Clinical Application" in
press Archivum Immunologiae et Therapiae Experimentalis,
4)Półgęsek E., Jaworska A., Jankowski M., Kopiński P.,Goc A. Silencing of HER2 by siRNA induces
apoptosis in non-small cell lung cancer cell line A549. Journal of International Federation of Clinical
Chemistry and Laboratory Medicine. in press
5)Jankowski M., Kopiński P., Goc A. “Perspektywy immunoterapii niedrobnokomórkowego raka płuc przy
użyciu allogenicznych komórek dendrytycznych.” XX Spotkanie Polskiej Grupy European Respiratory
Society 8-11.03.2009 Korbielów, book of abstracts s.13.
6) P Kopiński, M Dancewicz, E Półgęsek, M Jankowski, A Jaworska: “SiRNA mediated growth factor
receptors inhibition in A549 cell model of lung cancer gene therapy: insulin-like growth factor-Ireceptor
(IGF-R1) blockade produces changes that potentially induce anti-tumor immunity”. Eur. Respir. J. 2008 Vol.
32 suppl 52 s. 225s. 18th ERS Annual Congress. Berlin, Germany, 4-8 X 2008 (ERS Thoracic Oncology
Award)
7)Kopinski P., Kowalewski J., Dancewicz M., Jankowski M., Polgesek E., Jaworska A., Goc A.:“Phenotype
pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomemon. Effect of
transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (sh)RNA
sequences” – accepted for the 19th ERS Annual Congress. Vienna, Austria
Honors & Awards
McKinsey Leadership Seminar 2007
Primus Inter Pares (nationwide contest for the best university student) 2nd prize. 2004
Research Grants of Polish Society for Genetics 2007 and 2008